Metabolic dysregulation contributes to the development of dysferlinopathy
Ontology highlight
ABSTRACT: Dysferlin is a transmembrane protein that plays a prominent role in membrane repair of damaged muscle fibers. Accordingly, mutations of the dysferlin gene cause progressive muscular dystrophies, collectively referred to as dysferlinopathies for which no effective treatment exists. Unexpectedly, experimental approaches that successfully restore membrane repair fail to prevent a dystrophic phenotype, suggesting that additional, hitherto unknown dysferlin-dependent functions contribute to the development of the pathology. Our experiments revealed an altered metabolic phenotype in dysferlin-deficient muscles, characterized by 1) mitochondrial abnormalities and elevated death signaling and 2) increased glucose uptake, reduced glycolytic protein levels, and a pronounced glycogen accumulation. Strikingly, elevating mitochondrial volume density and muscle glycogen accelerates disease progression while improvement of mitochondrial function and recruitment of muscle glycogen with exercise ameliorated functional parameters in a mouse model of dysferlinopathy. Collectively, our results not only shed light on a metabolic function of dysferlin, but also imply new therapeutic avenues aimed at promoting mitochondrial function and normalizing muscle glycogen to ameliorate dysferlinopathies, complementing efforts that target membrane repair.
INSTRUMENT(S): Orbitrap Fusion Lumos, timsTOF Ultra
ORGANISM(S): Mus Musculus (ncbitaxon:10090)
SUBMITTER:
Alexander Schmidt
PROVIDER: MSV000096818 | MassIVE | Fri Jan 10 04:30:00 GMT 2025
SECONDARY ACCESSION(S): PXD059629
REPOSITORIES: MassIVE
ACCESS DATA